Instructions for Taurine eye drops 4 %
English product name
Taurine
Release form
eye drops 4%: fl-capeln. 5 ml or 10 ml
Description
Eye drops are colorless, transparent.
1 ml
taurin 40 mg
Auxiliary substances:
methylparahydroxybenzoate - 1 mg,
purified water - up to 1 ml.
5 ml - bottle-droppers polymer (1) - packs of cardboard.
10 ml - polymer drip bottles (1) - cardboard packs.
ATC codes
S01XA Other preparations for the treatment of eye diseases
Clinical-pharmacological groups / Group affiliation
Preparation stimulating regeneration processes for local use in ophthalmology
Active substance
taurin
Pharmacotherapy group
- Metabolic agent
Pharmacological effect
Taurine is a natural product of the exchange of sulfur amino acids: cysteine, cysteamine, methionine. Taurine has osmoregulatory and membrane-protective properties, positively influences the phospholipid composition of cell membranes, normalizes the exchange of calcium and potassium ions in cells, and improves the conditions for nerve impulse.
It stimulates reparative and regenerative processes in cases of diseases of dystrophic character and/or diseases accompanied by a sharp disruption of the metabolism of the eye tissues.
Testimony Taurine:
- Dystrophic diseases of retina,
- including hereditary tapetoretinal degeneration;
- Corneal dystrophy cataract (senile, diabetic, traumatic, radiotherapy);
- corneal injury (as a stimulant of reparative processes);
- primary open-angle glaucoma (combined with beta-adrenolocators for topical use in ophthalmology).
Dosage, Course and Dosage
The dosage regimen depends on the indications and the dosage form of the drug used.
Use in children
It is contraindicated under the age of 18 years (effectiveness and safety are not established).
- Nosology Taurine (ICD codes)
- H18.4
- Degeneration of the cornea
- H18.5
- Hereditary corneal dystrophy
- H25
- Cataract
- H26
- Other cataracts
- H35.0
- Background retinopathy and retinal vascular changes
- H35.4
- Peripheral retinal degeneration
- H35.5
- Hereditary retinal dystrophies
- H36.0
- Diabetic retinopathy
- H40.1
- Primary open-angle glaucoma
- S05
- Eye injury
